z-logo
open-access-imgOpen Access
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Hyderabad cohort of the A1chieve study
Author(s) -
Santosh Ramakrishnan,
Ravi Mehrotra,
Nadiminty Ganapathi Sastry
Publication year - 2013
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.122130
Subject(s) - insulin aspart , insulin detemir , medicine , insulin , basal insulin , endocrinology , diabetes mellitus , type 2 diabetes , basal (medicine) , cohort , hypoglycemia
The A1chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care across four continents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here